Logo image of MAMA

MAMA'S CREATIONS INC (MAMA) Stock Fundamental Analysis

USA - NASDAQ:MAMA - US56146T1034 - Common Stock

10.51 USD
-0.11 (-1.04%)
Last: 9/29/2025, 11:53:12 AM
Fundamental Rating

5

Taking everything into account, MAMA scores 5 out of 10 in our fundamental rating. MAMA was compared to 89 industry peers in the Food Products industry. MAMA has an average financial health and profitability rating. MAMA is valued quite expensively, but it does show have an excellent growth rating. With these ratings, MAMA could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year MAMA was profitable.
In the past year MAMA had a positive cash flow from operations.
Of the past 5 years MAMA 4 years were profitable.
MAMA had a positive operating cash flow in each of the past 5 years.
MAMA Yearly Net Income VS EBIT VS OCF VS FCFMAMA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M

1.2 Ratios

MAMA has a Return On Assets of 8.83%. This is amongst the best in the industry. MAMA outperforms 88.76% of its industry peers.
The Return On Equity of MAMA (15.29%) is better than 82.02% of its industry peers.
Looking at the Return On Invested Capital, with a value of 12.32%, MAMA belongs to the top of the industry, outperforming 87.64% of the companies in the same industry.
Industry RankSector Rank
ROA 8.83%
ROE 15.29%
ROIC 12.32%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MAMA Yearly ROA, ROE, ROICMAMA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200 -400

1.3 Margins

MAMA's Profit Margin of 3.34% is fine compared to the rest of the industry. MAMA outperforms 64.04% of its industry peers.
MAMA's Profit Margin has declined in the last couple of years.
MAMA has a Operating Margin (4.26%) which is comparable to the rest of the industry.
MAMA's Operating Margin has declined in the last couple of years.
MAMA's Gross Margin of 24.56% is in line compared to the rest of the industry. MAMA outperforms 58.43% of its industry peers.
MAMA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.26%
PM (TTM) 3.34%
GM 24.56%
OM growth 3Y185.5%
OM growth 5Y-8.49%
PM growth 3YN/A
PM growth 5Y-7.87%
GM growth 3Y0.31%
GM growth 5Y-3.01%
MAMA Yearly Profit, Operating, Gross MarginsMAMA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MAMA is still creating some value.
Compared to 5 years ago, MAMA has more shares outstanding
MAMA Yearly Shares OutstandingMAMA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 10M 20M 30M
MAMA Yearly Total Debt VS Total AssetsMAMA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 10M 20M 30M 40M

2.2 Solvency

An Altman-Z score of 15.21 indicates that MAMA is not in any danger for bankruptcy at the moment.
The Altman-Z score of MAMA (15.21) is better than 96.63% of its industry peers.
The Debt to FCF ratio of MAMA is 0.84, which is an excellent value as it means it would take MAMA, only 0.84 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of MAMA (0.84) is better than 89.89% of its industry peers.
MAMA has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
MAMA's Debt to Equity ratio of 0.05 is fine compared to the rest of the industry. MAMA outperforms 75.28% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.84
Altman-Z 15.21
ROIC/WACC1.39
WACC8.85%
MAMA Yearly LT Debt VS Equity VS FCFMAMA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M

2.3 Liquidity

MAMA has a Current Ratio of 1.58. This is a normal value and indicates that MAMA is financially healthy and should not expect problems in meeting its short term obligations.
MAMA has a Current ratio of 1.58. This is comparable to the rest of the industry: MAMA outperforms 53.93% of its industry peers.
MAMA has a Quick Ratio of 1.15. This is a normal value and indicates that MAMA is financially healthy and should not expect problems in meeting its short term obligations.
MAMA has a Quick ratio of 1.15. This is in the better half of the industry: MAMA outperforms 68.54% of its industry peers.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.15
MAMA Yearly Current Assets VS Current LiabilitesMAMA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 5M 10M 15M 20M

8

3. Growth

3.1 Past

The earnings per share for MAMA have decreased strongly by -15.38% in the last year.
MAMA shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.61% yearly.
The Revenue has grown by 19.34% in the past year. This is quite good.
Measured over the past years, MAMA shows a very strong growth in Revenue. The Revenue has been growing by 29.59% on average per year.
EPS 1Y (TTM)-15.38%
EPS 3YN/A
EPS 5Y17.61%
EPS Q2Q%0%
Revenue 1Y (TTM)19.34%
Revenue growth 3Y37.85%
Revenue growth 5Y29.59%
Sales Q2Q%24.03%

3.2 Future

Based on estimates for the next years, MAMA will show a very strong growth in Earnings Per Share. The EPS will grow by 35.60% on average per year.
MAMA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 25.09% yearly.
EPS Next Y-32%
EPS Next 2Y61.45%
EPS Next 3Y35.6%
EPS Next 5YN/A
Revenue Next Year35.5%
Revenue Next 2Y32.07%
Revenue Next 3Y25.09%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
MAMA Yearly Revenue VS EstimatesMAMA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M 200M
MAMA Yearly EPS VS EstimatesMAMA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.1 -0.1 0.2

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 95.55, which means the current valuation is very expensive for MAMA.
Compared to the rest of the industry, the Price/Earnings ratio of MAMA indicates a slightly more expensive valuation: MAMA is more expensive than 60.67% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.54. MAMA is valued rather expensively when compared to this.
With a Price/Forward Earnings ratio of 44.80, MAMA can be considered very expensive at the moment.
MAMA's Price/Forward Earnings ratio is in line with the industry average.
MAMA is valuated expensively when we compare the Price/Forward Earnings ratio to 23.05, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 95.55
Fwd PE 44.8
MAMA Price Earnings VS Forward Price EarningsMAMA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MAMA is valued a bit more expensive than the industry average as 66.29% of the companies are valued more cheaply.
The rest of the industry has a similar Price/Free Cash Flow ratio as MAMA.
Industry RankSector Rank
P/FCF 87.42
EV/EBITDA 45.1
MAMA Per share dataMAMA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

A more expensive valuation may be justified as MAMA's earnings are expected to grow with 35.60% in the coming years.
PEG (NY)N/A
PEG (5Y)5.43
EPS Next 2Y61.45%
EPS Next 3Y35.6%

0

5. Dividend

5.1 Amount

No dividends for MAMA!.
Industry RankSector Rank
Dividend Yield N/A

MAMA'S CREATIONS INC

NASDAQ:MAMA (9/29/2025, 11:53:12 AM)

10.51

-0.11 (-1.04%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)09-08 2025-09-08/amc
Earnings (Next)12-15 2025-12-15
Inst Owners68.09%
Inst Owner ChangeN/A
Ins Owners4.07%
Ins Owner Change1.62%
Market Cap425.65M
Analysts82
Price Target14.28 (35.87%)
Short Float %4.4%
Short Ratio7.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)27.01%
Min EPS beat(2)6.95%
Max EPS beat(2)47.06%
EPS beat(4)3
Avg EPS beat(4)5.69%
Min EPS beat(4)-73.86%
Max EPS beat(4)47.06%
EPS beat(8)6
Avg EPS beat(8)6.14%
EPS beat(12)10
Avg EPS beat(12)71.85%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)4.09%
Min Revenue beat(2)2.61%
Max Revenue beat(2)5.57%
Revenue beat(4)4
Avg Revenue beat(4)4.3%
Min Revenue beat(4)2.61%
Max Revenue beat(4)6.15%
Revenue beat(8)7
Avg Revenue beat(8)4.64%
Revenue beat(12)11
Avg Revenue beat(12)4.36%
Revenue beat(16)13
Avg Revenue beat(16)3.22%
PT rev (1m)35.48%
PT rev (3m)35.48%
EPS NQ rev (1m)-94.64%
EPS NQ rev (3m)-94.74%
EPS NY rev (1m)-63.26%
EPS NY rev (3m)-63.26%
Revenue NQ rev (1m)14.64%
Revenue NQ rev (3m)14.64%
Revenue NY rev (1m)15.45%
Revenue NY rev (3m)15.45%
Valuation
Industry RankSector Rank
PE 95.55
Fwd PE 44.8
P/S 3.14
P/FCF 87.42
P/OCF 51.43
P/B 14.39
P/tB 23.3
EV/EBITDA 45.1
EPS(TTM)0.11
EY1.05%
EPS(NY)0.23
Fwd EY2.23%
FCF(TTM)0.12
FCFY1.14%
OCF(TTM)0.2
OCFY1.94%
SpS3.35
BVpS0.73
TBVpS0.45
PEG (NY)N/A
PEG (5Y)5.43
Profitability
Industry RankSector Rank
ROA 8.83%
ROE 15.29%
ROCE 15.85%
ROIC 12.32%
ROICexc 16.6%
ROICexgc 28.56%
OM 4.26%
PM (TTM) 3.34%
GM 24.56%
FCFM 3.59%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y219.36%
ROICexcg growth 5Y-6.93%
ROICexc growth 3Y244.9%
ROICexc growth 5Y-16.03%
OM growth 3Y185.5%
OM growth 5Y-8.49%
PM growth 3YN/A
PM growth 5Y-7.87%
GM growth 3Y0.31%
GM growth 5Y-3.01%
F-Score6
Asset Turnover2.65
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.84
Debt/EBITDA 0.16
Cap/Depr 93.4%
Cap/Sales 2.51%
Interest Coverage 16.21
Cash Conversion 87.88%
Profit Quality 107.63%
Current Ratio 1.58
Quick Ratio 1.15
Altman-Z 15.21
F-Score6
WACC8.85%
ROIC/WACC1.39
Cap/Depr(3y)80.56%
Cap/Depr(5y)82.95%
Cap/Sales(3y)1.84%
Cap/Sales(5y)1.69%
Profit Quality(3y)128.45%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15.38%
EPS 3YN/A
EPS 5Y17.61%
EPS Q2Q%0%
EPS Next Y-32%
EPS Next 2Y61.45%
EPS Next 3Y35.6%
EPS Next 5YN/A
Revenue 1Y (TTM)19.34%
Revenue growth 3Y37.85%
Revenue growth 5Y29.59%
Sales Q2Q%24.03%
Revenue Next Year35.5%
Revenue Next 2Y32.07%
Revenue Next 3Y25.09%
Revenue Next 5YN/A
EBIT growth 1Y-18.24%
EBIT growth 3Y293.57%
EBIT growth 5Y18.58%
EBIT Next Year189.14%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-39.96%
FCF growth 3Y17.93%
FCF growth 5Y-44.38%
OCF growth 1Y-4.2%
OCF growth 3Y78.52%
OCF growth 5Y23.39%